Placental Risk Assessment Study for Pregnancy Care
This study, called "Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation," is looking at how to better predict placental insufficiency (when the placenta doesn't work as well as it should) and stillbirth. Researchers will collect data throughout your pregnancy, including ultrasound and blood tests, as well as information from your delivery and about your newborn. The goal is to create a model that can predict placental insufficiency. You may be able to join if you are pregnant, aged 15 to 50, planning to deliver at Oregon Health & Science University, and are less than 22 weeks pregnant with a single baby and no known major fetal problems. The study aims to enroll 640 participants. The main measure of success is to see how many participants experience placental insufficiency at the time of delivery or up to 28 days afterward.
- Study design
- This is an observational study, meaning researchers will collect information without providing specific treatments. It aims to include 640 pregnant participants.
- What's involved
- You would have monitoring with ultrasound and blood tests at three points during your pregnancy. Data from your delivery and about your newborn would also be collected.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your delivery and newborn data will be collected up to 28 days following delivery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Karen Gibbins · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of participants with placental insufficiency compositeAt time of delivery to 28 days following delivery
The composite is made of the following: stillbirth and neonatal death, severe forms of hypertensive disease, placental abruption, birthweight below the 3rd percentile, umbilical cord arterial pH\<7, and/or placental primary indication for delivery (FGR, oligohydramnios, abnormal fetal testing)